SCHEMBL14261346

SCHEMBL14261346

OBc1ccc(Cl)cc1Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 6/20 0.48
▸ HSD17B10 Q99714 2/20 0.48
▸ TP53 P04637 3/20 0.48
▸ CYP3A4 P08684 4/20 0.42
▸ TDP1 Q9NUW8 3/20 0.42
▸ ALDH1A1 P00352 3/20 0.42
▸ CASP1 P29466 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ AHR P35869 1/20 0.41
▸ MAPK1 P28482 3/20 0.39
▸ LMNA P02545 2/20 0.38
▸ USP2 O75604 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ IDO1 P14902 1/20 0.38
▸ MAPT P10636 2/20 0.38
▸ NR1I2 O75469 1/20 0.38
▸ TTR P02766 1/20 0.38
▸ PGR P06401 1/20 0.38
▸ HSP90AA1 P07900 1/20 0.38
▸ ADORA3 P0DMS8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13300191 0.80 TSHR (0.48) TSHRHSD17B10TP53CYP3A4TDP1
SCHEMBL21889238 0.78 HSD17B10 (0.54) HSD17B10CYP3A4TTRHPGD
SCHEMBL7097753 0.76 PPARG (0.38) TSHRHSD17B10TP53CYP3A4TDP1
SCHEMBL7065067 0.74 TP53 (0.78) TSHRHSD17B10TP53CYP3A4TDP1
SCHEMBL21791937 0.73 ALDH1A1 (0.36) TSHRHSD17B10TP53CYP3A4TDP1
SCHEMBL20459459 0.73 MAPT (0.46) TSHRHSD17B10TP53CYP3A4TDP1
SCHEMBL19339721 0.72 ERN1 (0.57) HSD17B10TDP1ALDH1A1TTRHPGD
SCHEMBL13464298 0.71 CYP3A4 (0.46) TSHRHSD17B10CYP3A4TDP1ALDH1A1
SCHEMBL13952599 0.71 TDP1 (0.45) TSHRHSD17B10TP53CYP3A4TDP1
SCHEMBL464507 0.69 AHR (0.64) TSHRHSD17B10TP53CYP3A4TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3679023-B1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2022-11-02 — — EP disclosed
US-20210188772-A1 Salts of Methyl 6-(2,4-Dichlorophenyl)-5-[4-[(3S)-1-(3-Fluoropropyl)Pyrrolidin-3-yl]Oxyphenyl]-8,9-Dihydro-7H-Benzo[7]Annulene-2-Carboxylate and Preparation Process Thereof SANOFI (FR) 2021-06-24 — — US disclosed
US-20210188771-A1 Process for the Preparation of Methyl 6-(2,4-Dichlorophenyl)-5-[4-[(3S)-1-(3-Fluoropropyl)Pyrrolidin-3-yl]Oxyphenyl]-8,9-Dihydro-7H-Benzo[7]Annulene-2-Carboxylate SANOFI (FR) 2021-06-24 — — US disclosed
EP-3386987-B1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME ROHM & HAAS ELECT MATERIALS KOREA LTD (KR) 2020-04-15 — — EP disclosed
WO-2017099360-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) 2017-06-15 — — WO disclosed
WO-2008027812-A2 IMIDAZOPYRIDINE AND IMIDAZOPYRIMIDINE DERIVATIVES FOREST LABORATORIES HOLDINGS LIMITED (BM) 2008-03-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210188772-A1 Salts of Methyl 6-(2,4-Dichlorophenyl)-5-[4-[(3S)-1-(3-Fluoropropyl)Pyrrolidin-3-yl]Oxyphenyl]-8,9-Dihydro-7H-Benzo[7]Annulene-2-Carboxylate and Preparation Process Thereof REN, PKD1, AGTR1 TSHR 1907/4885HSD17B10 1225/4885TP53 2163/4885
US-20210188771-A1 Process for the Preparation of Methyl 6-(2,4-Dichlorophenyl)-5-[4-[(3S)-1-(3-Fluoropropyl)Pyrrolidin-3-yl]Oxyphenyl]-8,9-Dihydro-7H-Benzo[7]Annulene-2-Carboxylate ALG8, LIG3, UGT2B7 TSHR 4261/4885HSD17B10 1004/4885TP53 4035/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback